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ABSTRACT
Background: Laparoscopic Nissen fundoplication (LNF)
provides long-term improvement in the typical symptoms
of gastroesophageal reflux disease. Few studies have pro-
spectively addressed LNF in the community hospital or the
effect of LNF on specific atypical symptoms, other related
gastrointestinal symptoms, and weight change.
Methods: Data were collected prospectively on consec-
utive patients having LNF. Three typical, 6 atypical, and 3
other gastrointestinal symptoms were studied.
Results: Short-term data on 91 patients and long-term
data on 84 patients were studied. Overall long-term im-
provement was 98%. Regarding typical symptoms, the
greatest improvement occurred in heartburn and regurgi-
tation. Regarding atypical symptoms, the greatest im-
provement occurred in cough and sore throat, but chest
pain, hoarseness, and throat clearing also showed signif-
icant durable improvement. Bloating, nausea, and diar-
rhea showed no significant change from preoperative to
postoperative surveys. Mild weight loss was common.
Conclusion: LNF can be safely performed in a commu-
nity hospital with results equal to those of university
hospitals. Improvement in typical symptoms was greater
than improvement in atypical symptoms, but results for
both were significant and durable. Nonspecific gastroin-
testinal symptoms, such as nausea, bloating, and diarrhea,
may be unrelated to Nissen fundoplication.
Key Words: Laparoscopy, Nissen fundoplication, Com-
munity hospital.
INTRODUCTION
Laparoscopic Nissen fundoplication (LNF) was first intro-
duced by Dallemagne et al in 1991 in Belgium.1 Since its
initial description, LNF has gained wide acceptance from
surgeons and popularity with patients in the treatment of
gastroesophageal reflux disease (GERD). Many short- and
long-term studies have shown its effectiveness in the treat-
ment of the classical symptoms of GERD, which include
heartburn, regurgitation, and dysphagia. Results of pro-
spective and retrospective studies with follow-up of 5 to
10 years confirm its utility.2–6 However, most studies have
been based on patients treated in large university hospi-
tals. Although retrospective studies have shown equiva-
lent results, few of the prospective studies of LNF have
been performed in a community setting.7 The response of
atypical GERD symptoms, such as cough, hoarseness,
throat clearing, chest pain, and asthma, to LNF performed
in any setting remains controversial.8–10
We sought to answer the following 3 questions1: Can LNF
performed in a community hospital replicate the improve-
ment in typical symptoms reported by university based
series?2 Can specific atypical symptoms be expected to
improve after LNF?3 Are nonspecific GI symptoms im-
proved or are they worsened as a result of the fundopli-
cation procedure?
METHODS
Consecutive patients at New Hanover Regional Medical
Center, a 690-bed community, nonuniversity teaching
hospital, undergoing LNF by the same surgeon (JH) from
October 2001 to August 2005 were studied. The institu-
tional review board approved the study design. Patients
with large, paraesophageal hernias, intrathoracic stomach,
or those undergoing a nonelective repair were excluded.
Additionally, those who underwent a Toupet type fundo-
plication or other partial wrap procedure were excluded.
In order of frequency, patients were referred for surgical
treatment by gastroenterologists, internal medicine spe-
cialists, family practitioners, otolaryngologists, other sur-
geons, and by self referral.
For evaluating symptoms, we considered the Visick grad-
ing system, but wished to utilize a more simple system to
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SCIENTIFIC PAPERmaximize the completion rate.11 We used a modified ver-
sion of the previously validated Allen scoring system.12
Twelve distinct GI symptoms were graded individually by
the patient as none, mild, moderate, or severe, and con-
verted to a numeric score from 0 (none) to 3 (severe).
Preoperative, postoperative, and long-term surveys all
used the same scoring system. The 3 typical symptoms
were defined as heartburn, regurgitation, and difficulty
swallowing. Atypical symptoms investigated were chest
pain, cough, hoarseness, sore throat, throat clearing, and
asthma. Nonspecific GI symptoms studied consisted of
nausea, bloating, and diarrhea.
All patients had been previously treated or were currently
under treatment with proton pump inhibitor (PPI) ther-
apy. Patients with typical GERD symptoms who had an
appropriate response to PPI therapy and return of symp-
toms when medications were stopped were considered to
have classical reflux and did not undergo an esophageal
pH probe, although in some patients this had been per-
formed before referral. All patients with atypical symp-
toms or a poor response to PPI therapy underwent a
preoperative esophageal pH study. All patients underwent
preoperative esophagogastroduodenoscopy (EGD), ei-
ther before referral or by the operating surgeon, and
esophageal manometry.
At the laparoscopic repair, the gastroesophageal junction
was circumferentially mobilized, the short-gastric vessels
were divided routinely, and the gastric fundus was com-
pletely mobilized. Two sutures were routinely placed to
close the crus posterior to the esophagus. Three gastro-
gastric sutures, incorporating the esophagus, were then
placed over a 54- to 60-French bougie to construct a 2-cm
floppy Nissen wrap.
Patients were seen in follow-up in the office at 1 to 2
weeks and then at 6 weeks postoperatively. Question-
naires were completed at the preoperative and each of the
postoperative office visits to assess the 12 GI symptoms
described, and information regarding weight loss, early
satiety, increased flatus, and response to surgery were
recorded. The long-term survey was identical to the short-
term survey and was conducted by one of the authors
(MR, AB) by phone between August and October of 2005.
Exhaustive attempts were made to locate and contact
every patient.
Patient weights were recorded at all visits. Early satiety
and increased flatus, compared with that preoperatively,
was scored as either present or absent. Patients scored
their overall response to surgery as marked improve-
ment,2 some improvement,1 no change (0), somewhat
worse (-1), and much worse (-2). As data were collected,
they were entered into a database.
Mean category scores were calculated, and paired t tests
were conducted to compare preoperative scores with
those of long-term follow-up. To assess changes in indi-
vidual symptoms, paired t tests were conducted for each
symptom; however, to control for the number of individ-
ual t tests, the significance level was adjusted to 0.01.
RESULTS
The study comprised 35 men (38%) and 56 women (62%).
The mean age was 46.8 12.70 years (range, 18 to 74). No
perioperative or postoperative deaths occurred, although
2 patients died 1 year later; 1 after complications of gastric
bypass surgery performed at an outside institution, and 1
from an apparent suicide. Conversion to an open proce-
dure was not required. The average length of stay was
1.10.43 days (range, 7 hours to 2 days). Three patients
required a second operation: 1 for a port-site hernia re-
pair, 1 for laparoscopic conversion to a Toupet for post-
operative dysphagia, and 1 for a laparoscopic repair of a
herniated wrap after a fall. One patient required 2 oper-
ations: laparoscopic repair of a slipped wrap initially fol-
lowed by a second recurrence with conversion to a Collis-
Nissen gastroplasty to correct esophageal shortening.
Preoperative pH study of the esophagus was completed in
36 patients, (40%) with an average preoperative De-
Meester score of 53.97 (range, 7.70 to 363.00). Manometry
was done on 73 patients (80%), and the average lower
esophageal sphincter pressure was 20.54 mm Hg (range, 0
to 56). EGD was completed on 91 (100%) patients. Esoph-
agitis was present in 36 patients (40%), but in more than
half the condition was considered mild. Eight patients had
a Schatzki ring, and in 3 there was significant stricture
formation.
Of the 91 patients who underwent LNF during the study
period, 94% of preoperative and short-term surveys were
completed. Long-term data were collected on 85% of the
84 patients who were more than 6 months postoperative.
Mean time from surgery to long-term survey was
24.611.41 months (range, 6 to 46.5). Only individuals
who completed all surveys were used in the final symp-
tom comparative analysis (n69).
Typical symptoms were more common than atypical
symptoms at presentation with 93% of patients complain-
ing of significant typical symptoms (moderate or severe,
score of 2 or 3), while 74% complained of significant
atypical symptoms. While 71% had mixed significant typ-
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significant typical symptoms, 7% had only atypical symp-
toms. Fifty-two percent of patients reported at least one
significant nonspecific GI symptom. No patient under-
went antireflux surgery for nonspecific GI symptoms with-
out at least one significant typical or atypical symptom.
The mean scores for each of the 12 GI symptoms from
preoperative through long-term follow-up are summa-
rized in Table 1. Prevalence of preoperative typical symp-
toms was heartburn in 95%, regurgitation in 98%, and
dysphagia in 72%. Heartburn and regurgitation had the
greatest overall improvements of typical symptoms, while
cough and sore throat had the greatest improvements of
atypical symptoms. Prevalence of preoperative atypical
symptoms was throat clearing in 86%, cough in 75%, chest
pain in 75%, hoarseness in 63%, sore throat in 53%, and
asthma in 34%. Of the atypical symptoms, chest pain,
cough, hoarseness, sore throat, and throat clearing all
showed statistically significant improvement. Asthma did
not show significant improvement. Typical symptoms
showed greater improvement than atypical symptoms did,
but both were statistically significant (Table 2).
Although atypical symptoms were prevalent in our study,
their severity was less than that of typical ones (mean
score: 1.90.61 typical, 1.10.68 atypical). Table 3 sum-
marizes those symptoms present at any time during the
study and their change by individual patient over time.
Early satiety and increased flatus were both common after
surgery. At short-term follow-up, 96% of patients reported
early satiety. This dropped to 78% at long-term follow-up.
Increased flatus was stable throughout the postoperative
period with 79% and 78% reporting it at short- and long-
term surveys.
Mean objective short-term weight loss was 6.65.56
pounds (range, 7 lb gain to 43 lb loss). Mean subjective
long-term weight loss was 7.013.32 lbs.
Overall subjective patient improvement was high. At the
short-term evaluation, 100% of patients felt they were
better: 87% reported marked improvement, and 13% some
improvement. This improvement was durable with 98%
remaining improved at long-term follow-up: 86% reported
marked improvement, 12% some improvement, 1% no
change, and 1% worse.
DISCUSSION
Many published studies address the impact of LNF on the
typical symptoms of GERD, with patient satisfaction of
86% to 93% at 5 years and 10 years after surgery reported
Table 1.
Symptom Responses* After Laparoscopic Nissen Fundoplication
Symptom Pre-op Short-term Long-term % Decrease P Value
Typical
Heartburn 2.3  0.81 0.1  0.32 0.6  0.98 74%  0.01
Regurgitation 2.1  0.76 0.1  0.38 0.3  0.72 86%  0.01
Dysphagia 1.3  1.09 0.7  0.72 0.6  0.98 54%  0.01
Atypical
Chest Pain 1.4  1.05 0.5  0.66 0.7  0.94 50%  0.01
Cough 1.2  0.97 0.4  0.63 0.5  0.76 58%  0.01
Hoarseness 1.2  1.05 0.4  0.66 0.6  0.84 50%  0.01
Sore Throat 0.9  0.98 0.2  0.44 0.4  0.89 56%  0.01
Throat Clearing 1.5  0.97 0.6  0.66 0.8  0.95 47%  0.01
Asthma 0.5  0.85 0.2  0.48 0.4  0.82 20% ns
Nonspecific GI
Nausea 0.8  0.96 0.2  0.79 0.4  0.80 50% ns
Bloating 1.2  1.16 0.7  0.73 1.0  1.13 31% ns
Diarrhea 0.8  0.96 0.45  0.71 0.5  0.85 50% ns
*Modified Allen scores
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demonstrate a similar community hospital response with
98% of patients stating they were improved (86% mark-
edly improved) at a mean of 2 years following surgery.
Although our follow-up duration was shorter compared
with that of some studies, patient satisfaction remains
durable across time.6
The most impressive response of LNF is on relief of heart-
burn and regurgitation. In our patients, improvement of
heartburn was achieved in 91% with complete resolution
66%. Regurgitation improved in 87% with complete reso-
lution in 79%. These results compare favorably with re-
sults reported in the literature.2,4,7
Response to dysphagia is difficult to predict, with lack of
improvement varying from 1% to 37% in reported stud-
ies.6,7,14–16 The mechanism of dysphagia before surgery
may be completely different than that taking place after
surgery. Preoperative difficulty swallowing from GERD is
Table 2.
Summary of Responses of Symptoms* After Surgery
Category Preop Short-term Long-term % Decrease P Value
Typical 1.9  0.61 0.3  0.32 0.5  0.57 74%  0.01
Atypical 1.1  0.68 0.4  0.34 0.5  0.55 55%  0.01
Non-specific GI 1.0  0.87 0.4  0.49 0.6  0.68 40% ns
*Modified Allen scores.
Table 3.
Specific Symptoms Responses* After Laparoscopic Nissen Fundoplication
Symptoms by Individual Prevalence†
(n) %
Resolved
(n) %
Improved†
(n) %
No change
(n) %
Worsened
(n) %
Typical
Heartburn (67) 97% (44) 66% (61) 91% (4) 6% (2) 3%
Regurgitation (67) 97% (53) 79% (58) 87% (4) 6% (5) 7%
Dysphagia (55) 80% (28) 51% (37) 67% (10) 18% (8) 15%
Atypical
Chest Pain (55) 80% (27) 49% (38) 69% (9) 16% (8) 15%
Cough (55) 80% (35) 64% (42) 76% (6) 16% (7) 13%
Hoarseness (47) 68% (22) 47% (33) 70% (6) 13% (8) 17%
Sore Throat (41) 59% (25) 61% (31) 76% (2) 5% (8) 20%
Throat Clearing (60) 87% (26) 43% (40) 67% (12) 20% (8) 13%
Asthma (24) 35% (10) 42% (12) 50% (6) 25% (6) 25%
Non-specific GI
Nausea (32) 46% (16) 50% (19) 59% (6) 19% (7) 22%
Bloating (54) 78% (15) 28% (25) 46% (10) 19% (19) 35%
Diarrhea (40) 58% (18) 45% (24) 60% (8) 20% (8) 20%
All Typical (189) 91% (125) 66% (156) 83% (18) 9% (15) 8%
All Atypical (282) 68% (145) 51% (196) 70% (41) 15% (45) 16%
Non-specific GI (126) 61% (49) 39% (68) 54% (24) 19% (34) 27%
*Modified Allen scores.
†“Prevalence” is symptom at either preoperative or postoperative evaluation. “Improved” includes those patients whose symptoms
resolved.
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agus, with or without stricture formation from chronic
inflammation. Postoperative dysphagia may be a sign of
continued reflux pathology or may result from the wrap
itself. The broad range in prevalence among the reports
cited is due, at least partly, to the different definitions by
the authors. We chose a very loose definition and simply
asked the patient whether they had any difficulty swal-
lowing solids or liquids. The preoperative prevalence of
dysphagia in this study was 80%; 67% improved (51%
resolved), but 15% worsened in their symptom score.
While this result is within the reported range, we feel our
less stringent definition may provide a more realistic ex-
pectation of patients postoperatively.
Retrospective and prospective studies have looked at
change in atypical symptoms of GERD after laparoscopic
antireflux procedures.8–10,13,16,17 Most of these studies do
not separate the outcomes based on the surgical tech-
nique utilized and include a variety of different proce-
dures: Nissen, Collis-Belsey, Belsey, Toupet, and Hill.
Only one study looked solely at LNF, was done prospec-
tively, and was a symptom-based study.13 Given the con-
tinued controversy over outcomes based on the proce-
dure performed, it is difficult to know whether the
outcome of atypical symptoms is influenced by the type of
repair and, if so, what kind of results the surgeon and
patient can expect for atypical symptoms for any given
approach.6 We chose to examine a single approach, LNF,
to avoid confounding factors. Confusion is added from the
varying definition of atypical symptoms. Few authors re-
port the response to specific symptoms but rather lump all
atypical symptoms together or into classes: laryngeal,
chest/epigastric pain, and/or pulmonary symptoms.8–10,18
Included in the definition of atypical symptoms by differ-
ent authors are the following: asthma, chest pain, epigas-
tric pain, odynophagia, cough, hoarseness, globus, hali-
tosis, enamel loss, sore throat, vocal cord polyps,
indigestion, vomiting, choking, belching, wheezing, and
aspiration.
8–10,15,17–19
A large variation also exists in the reported response to
atypical symptoms. Improvement in atypical symptoms
ranges from 41% to 93% and resolution from 13% to
48%.8,9,13,18 This broad range in results is secondary to the
huge variation in study types, included symptoms, and
definition of “improved” and “resolved.” We chose a strict
definition of “resolved” for our data; even mild symptoms
were not considered resolved. With this strict definition,
our findings of overall resolution in 51% and improvement
in 70% of patients for a wide range of atypical symptoms
compares very favorably with results of other studies.
Our data show that the prevalence of atypical symptoms
varies from 35% to 80%, depending on the symptom. We
also found the majority of patients present with a mixed
typical and atypical symptom combination. Our results
also varied significantly by symptom. The greatest im-
provements were seen in cough and sore throat, while the
worst was seen in asthma. Had we lumped asthma and
cough together as “all pulmonary,” we would have missed
the improved potential to help patients with cough rather
than asthma as a symptom.
The presence of nonspecific GI symptoms (nausea, bloat-
ing, and diarrhea) encountered by patients who undergo
laparoscopic antireflux procedures is well document-
ed.3,4,5,8,15,16 Rates of postoperative bloating, 20% to 66%,
and diarrhea, 12% to 25%, have been previously report-
ed.3,4,5,15 These symptoms are frequently reported postop-
eratively without a preoperative comparison and errone-
ously attributed to the fundoplication.15 Because we
found these symptoms to be less severe than the reflux
symptoms for which the patient is referred, the patient
may indeed have recall bias in many of these reports as
they focus more on their relatively more severe reflux
symptoms and only notice the milder GI symptoms once
their reflux is relieved postoperatively. Our preoperative
survey of these nonspecific gastrointestinal symptoms
shows that they are relatively common and actually im-
prove more often than they worsen. We found no statis-
tically significant change in these symptoms from preop-
erative to long-term follow-up evaluation. This finding
demonstrates that their presence postoperatively may be
unrelated to the fundoplication itself.
Our high rates of early satiety and increased flatus are
higher than those in other reports. Weight loss has not
been previously reported after laparoscopic antireflux
procedures. Our high rate of early satiety (96%) may
explain the modest weight loss of 6.6lbs for the cohort.
We found satiety to improve over the long-term but did
not find the same for improvement in the increased flatus.
Seventy-eight percent of patients experienced this at an
average of 2 years of follow-up; this rate is higher than that
in other published data.2,15,16 Booth et al2 followed this
symptom for up to 8 years and found it to decrease from
55% at 2 to 5 years postoperatively to 38% at 5 to 8 years.
The high rate of early satiety among our patients may be
due to routine complete mobilization of the distal esoph-
agus and the utilization of the fundus in the wrap, thus
affecting its receptive-relaxation function.
Several weaknesses can be described in our study. Our
mean long-term follow-up of 24.6 months is considered
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some series. Our reported long-term data are subjective in
nature and based on symptoms rather than objective,
quantitative data. However, other studies have already
documented the short-term and very long-term results of
LNF, and our community data compare favorably.2–6 An-
vari and Allen3demonstrated in a large prospective study
that pH probe and manometry are poor predictors of
perceived severity as well as response to fundoplication.
Additionally, as fundoplication is typically done to control
symptoms, patient perception of the control of the symp-
toms for which they underwent surgery is the best deter-
minant of success.
CONCLUSION
LNF can safely be performed in a community setting with
results similar to those reported in large university based
practices. Typical symptoms show a greater response to
LNF than atypical symptoms. Most of the atypical symp-
toms show significant and durable responses. Increased
flatus, early satiety, and mild weight loss are common after
LNF. When seen postoperatively, nausea, bloating, and
diarrhea are not necessarily a side effect of the fundopli-
cation.
References:
1. Dellemagne B, Weerts JM, Jehas C, Markiewicz S, Lombard
R. Laparoscopic Nissen fundopliaction: preliminary report. Surg
Laparosc Endosc. 1991;1:138–143.
2. Booth MI, Stratford JJ, Dehn TCB. Results of laparoscopic
Nissen fundoplication at 2–8 years after surgery. Br J Surg.
2002;89:476–481.
3. Anvari M, Allen C. Five-year comprehensive outcomes eval-
uation in 181 patients after laparoscopic Nissen fundoplication.
J Am Coll Surg. 2003;196:51–57.
4. Lafullarde T, Watson DI, Jamieson GG, Myers JC, Game PA,
Devitt PG. Laparoscopic Nissen fundoplication: five-year results
and beyond. Arch Surg. 2001;136:180–184.
5. Bammer T, Hinder RA, Klaus A, Klingler PJ. Five- to eight-
year outcome of the first laparoscopic Nissen fundoplication.
J Gastrointest Surg. 2001;5:42–46.
6. Pessaux P, Arnaud JP, Delattre JF, Meyer C, Baulieux J,
Mosnier H. Laparoscopic antireflux sugery: five-year results and
beyond in 1340 patients. Arch Surg. 2005;140:946–951.
7. Althar RA. Laparoscopic anti-reflux surgery in the commu-
nity hospital setting: evaluation of 100 consecutive patients. JSLS.
1999;3(2):107–112.
8. So JBY, Zeitels SM, Rattner DW. Outcomes of atypical symp-
toms attributed to gastroesophageal reflux treated by laparo-
scopic fundoplication. Surgery. 1998;24:28–32.
9. Farrell TW, Richardson WS, Trus TL, Smith CD, Hunter JG.
Response of atypical symptoms of gastro-oesophageal reflux to
antireflux surgery. Br J Surg. 2001;88:1649–1652.
10. Johnson WE, Hagen JA, DeMeester TR, et al. Outcome of
respiratory symptoms after antireflux surgery on patients with
gastroesophageal reflux disease. Arch Surg. 1996;131:489–492.
11. Mughal MM, Bancewicz J, Marples M. Oesophageal manom-
etry and pH recording does not predict the bad results of Nissen
fundoplication. Br J Surg. 1990;77:43–45.
12. Allen CJ, Parameswaran K, Belda J, Anvari M. Reproducibil-
ity, validity, and responsiveness of a disease-specific symptom
questionnaire for gastroesophageal reflux disease. Dis Esopha-
gus. 2000;13:265–270.
13. Rakita S, Villadolid D, Thomas A, et al. Laparoscopic Nissen
fundoplication offers high patient satisfaction with relief of ex-
traesophageal symptoms of gastroesophageal reflux disease. Am
Surg. 2006;72:207–212.
14. Tucker L, Blatt C, Richardson NL, Richardson DT, Cassat JD,
Riechers TB. Laparoscopic Nissen fundoplication in a commu-
nity hospital: patient satisfaction survey. South Med J. 2005;98:
441–443.
15. Beldi G, Glattli A. Long-term gasto-intestinal symptoms after
laparoscopic Nissen fundoplication. Surg Laparosc Endosc Per-
cutan. 2002;12:316–319.
16. Peters JH, DeMeester TR, Crookes P, et al. The treatment of
gastroesophageal reflux disease with laparoscopic Nissen fun-
doplication: prospective evaluation of 100 patients with “typical”
symptoms. Ann Surg. 1998;228:40–50.
17. Duffy JP, Maggard M, Hiyama DT, et al. Laparoscopic Nissen
fundoplication improves quality of life in patients with atypical
symptoms of gastroesophageal reflux. Am Surg. 2003;69:833–838.
18. Chen RYM, Thomas RJS. Results of laparoscopic fundopli-
cation where atypical symptoms coexist with oesophageal re-
flux. A u s tNZJSurg. 2000;70:840–842.
19. Ritter DW, Vanderpool D, Westmoreland M. Laparoscopic
Nissen fundoplication for gastroesophageal reflux disease. Am J
Surg. 1997;174:715–717. Vol. 11, No. 1
JSLS (2007)11:66–71 71